These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4006329)

  • 1. Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.
    Edefonti A; Bettinelli A; Mondonico P; Claris Appiani A; Picca M; Cossu MM; Tentori F; Giani M; Rossi E
    Clin Nephrol; 1985 Apr; 23(4):207-11. PubMed ID: 4006329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
    Tinaztepe K; Akkök N; Tinaztepe B
    Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
    Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
    Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolytic-uremic syndrome in children and arterial hypertension].
    Habib R; Gagnadoux MF; Broyer M
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():37-43. PubMed ID: 6794528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome.
    Mehrazma M; Hooman N; Otukesh H
    Iran J Kidney Dis; 2011 Nov; 5(6):380-5. PubMed ID: 22057069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
    Kamioka I; Nozu K; Fujita T; Kaito H; Tanaka R; Yoshiya K; Iijima K; Nakanishi K; Yoshikawa N; Matsuo M
    Pediatr Int; 2007 Apr; 49(2):196-201. PubMed ID: 17445038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic and uremic syndrome in the child].
    Niaudet P
    Nephrol Ther; 2008 Feb; 4(1):34-40. PubMed ID: 17964233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
    Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
    Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic-uremic syndrome].
    Bláhová K
    Vnitr Lek; 2004 Jul; 50(7):519-25. PubMed ID: 15323259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinico-pathological characteristics and outcome in hemolytic-uremic syndrome of adults.
    Matsumae T; Takebayashi S; Naito S
    Clin Nephrol; 1996 Mar; 45(3):153-62. PubMed ID: 8706355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal histopathology in the hemolytic-uremic syndrome following shigellosis.
    Koster FT; Boonpucknavig V; Sujaho S; Gilman RH; Rahaman MM
    Clin Nephrol; 1984 Feb; 21(2):126-33. PubMed ID: 6373079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome.
    Fernández GC; Rubel C; Barrionuevo P; López L; Ramirez F; Díaz M; Isturiz MA; Palermo MS
    Pediatr Nephrol; 2002 May; 17(5):337-44. PubMed ID: 12042890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
    Imoberdorf G; Bianchetti MG; Rossi E; Gugler E; Oetliker OH
    Schweiz Med Wochenschr; 1993 Jul; 123(29):1439-44. PubMed ID: 8367702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR; Ramirez JA; Ruiz S; Caletti MG; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
    Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
    Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
    Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation changes associated with the hemolytic uremic syndrome.
    Gordjani N; Sutor AH
    Semin Thromb Hemost; 1998; 24(6):577-82. PubMed ID: 10066153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
    Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
    J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tissue factor circulating levels in children with hemolytic uremic syndrome caused by verotoxin-producing E. coli.
    Kamitsuji H; Nonami K; Murakami T; Ishikawa N; Nakayama A; Umeki Y
    Clin Nephrol; 2000 May; 53(5):319-24. PubMed ID: 11305804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.